|
|
synapsis
|
GO:0007129 |
34 |
0.357
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.346
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.209
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.177
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.145
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.141
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.122
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.105
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.098
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.096
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.090
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.084
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.082
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.078
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.068
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.064
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.064
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.062
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.062
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.062
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.062
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.058
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.056
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.055
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.053
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.052
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.052
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.052
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.052
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.052
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.050
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.050
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.050
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.050
|
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.050
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.047
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.047
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.046
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.046
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.046
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.045
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.044
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.042
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.041
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.041
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.040
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.040
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.040
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.040
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.040
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.039
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.039
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.038
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.038
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.038
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.037
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.037
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.036
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.036
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.036
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.035
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.035
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.035
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.035
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.035
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.035
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.034
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.033
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.033
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.032
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.031
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.031
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.031
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.031
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.031
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.030
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.030
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.030
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.030
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.030
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.030
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.030
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.029
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.029
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.029
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.029
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.029
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.029
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.029
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.029
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.028
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.028
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.028
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.028
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.028
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.028
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.028
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.028
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.028
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.028
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.027
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.027
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.027
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.027
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.027
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.027
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.027
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.027
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.027
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.027
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.027
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.026
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.026
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.026
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.026
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.026
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.025
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.025
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.025
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.025
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.025
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.025
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.025
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.025
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.024
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.024
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.024
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.024
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.024
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.024
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.023
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.023
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.023
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.023
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.023
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.023
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.023
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.023
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.023
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.023
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.022
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.022
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.022
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.022
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.021
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.021
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.021
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.021
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.021
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.021
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.021
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.021
|
|
|
|
embryonic heart tube anterior posterior pattern specification
|
GO:0035054 |
3 |
0.021
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.021
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.020
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.020
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.020
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.020
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.020
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.020
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.020
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.020
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.020
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.020
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.020
|
|
|
|
determination of left right asymmetry in nervous system
|
GO:0035545 |
1 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.019
|
|
|
|
regulation of brown fat cell proliferation
|
GO:0070347 |
1 |
0.019
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.019
|
|
|
|
aldosterone metabolic process
|
GO:0032341 |
2 |
0.019
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.019
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.019
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.019
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.019
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.019
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.019
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.018
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.018
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.018
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.018
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.018
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.018
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.018
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.018
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.018
|
|
|
|
forebrain neuron fate commitment
|
GO:0021877 |
13 |
0.018
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.018
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.018
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
learning
|
GO:0007612 |
98 |
0.018
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.018
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.018
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.017
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.017
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.017
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.017
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.017
|
|
|
|
response to histamine
|
GO:0034776 |
1 |
0.017
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.017
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.017
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.017
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.017
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.017
|
|
|
|
chiasma assembly
|
GO:0051026 |
6 |
0.017
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.016
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.016
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.016
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.016
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.016
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.016
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.016
|
|
|
|
response to follicle stimulating hormone
|
GO:0032354 |
1 |
0.016
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.016
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.016
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.016
|
|
|
|
roof plate formation
|
GO:0021509 |
1 |
0.016
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
0.016
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.016
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.016
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.016
|
|
|
|
gastrin induced gastric acid secretion
|
GO:0001698 |
1 |
0.016
|
|
|
|
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis
|
GO:0072309 |
3 |
0.015
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.015
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.015
|
|
|
|
midbrain hindbrain boundary morphogenesis
|
GO:0021555 |
4 |
0.015
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.015
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.015
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.015
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.015
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.015
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.015
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.015
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.015
|
|
|
|
fat cell proliferation
|
GO:0070341 |
4 |
0.015
|
|
|
|
respiratory system process
|
GO:0003016 |
25 |
0.015
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.015
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.015
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.015
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.015
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.015
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.015
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.015
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.014
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.014
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.014
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.014
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.014
|
|
|
|
regulation of mesenchymal cell proliferation involved in ureter development
|
GO:0072199 |
3 |
0.014
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.014
|
|
|
|
spinal cord association neuron differentiation
|
GO:0021527 |
14 |
0.014
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.014
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.014
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.014
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.014
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
brown fat cell proliferation
|
GO:0070342 |
1 |
0.014
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.014
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.014
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.014
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.014
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.014
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.014
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.014
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.014
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.014
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.014
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.014
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.013
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.013
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.013
|
|
|
|
negative regulation of posttranscriptional gene silencing
|
GO:0060149 |
1 |
0.013
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.013
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.013
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.013
|
|
|
|
positive regulation of ubiquitin protein transferase activity
|
GO:0051443 |
4 |
0.013
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.013
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.013
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.013
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.013
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.013
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.013
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.013
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.013
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.013
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.013
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.013
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.013
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.013
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.013
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.013
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.013
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.013
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.013
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.013
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.013
|
|
|
|
translation
|
GO:0006412 |
93 |
0.013
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.013
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.013
|
|
|
|
negative regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035359 |
3 |
0.013
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.013
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.013
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.013
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.013
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.013
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.013
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.013
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.013
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.012
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.012
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.012
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.012
|
|
|
|
progesterone biosynthetic process
|
GO:0006701 |
1 |
0.012
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.012
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.012
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.012
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.012
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.012
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.012
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.012
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.012
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.012
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.012
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.012
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.012
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.012
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.012
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.012
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.012
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.012
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.012
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.012
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.012
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.012
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.012
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.012
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
35 |
0.012
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.012
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.012
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.012
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.012
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.012
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.012
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.012
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.012
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.012
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.012
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.012
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.012
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.012
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.012
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.012
|
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.011
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.011
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.011
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.011
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.011
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.011
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.011
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.011
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.011
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.011
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.011
|
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.011
|
|
|
|
subpallium development
|
GO:0021544 |
20 |
0.011
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.011
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.011
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.011
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.011
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.011
|
|
|
|
olfactory pit development
|
GO:0060166 |
3 |
0.011
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.011
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.011
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.011
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.011
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.011
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.011
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.011
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.011
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.011
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.011
|
|
|
|
detection of mechanical stimulus involved in sensory perception of sound
|
GO:0050910 |
16 |
0.011
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.011
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.011
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.011
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.011
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.011
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.011
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.011
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.011
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.011
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.011
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.010
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.010
|
|
|
|
negative regulation of brown fat cell proliferation
|
GO:0070348 |
1 |
0.010
|
|
|
|
spongiotrophoblast layer developmental growth
|
GO:0090214 |
3 |
0.010
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.010
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.010
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.010
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.010
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.010
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.010
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.010
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.010
|
|
|
|
regulation of respiratory system process
|
GO:0044065 |
13 |
0.010
|
|
|
|
regulation of mast cell proliferation
|
GO:0070666 |
4 |
0.010
|
|
|
|
tor signaling
|
GO:0031929 |
21 |
0.010
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.010
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.010
|
|
|
|
positive regulation of ureteric bud formation
|
GO:0072107 |
3 |
0.010
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.010
|
|
|
|
regulation of neural retina development
|
GO:0061074 |
3 |
0.010
|
|
|
|
dorsal spinal cord development
|
GO:0021516 |
20 |
0.010
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.010
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.010
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.010
|
|
